Skip to main content
Clinical Trials/NCT05085860
NCT05085860
Recruiting
Not Applicable

Feasibility of Examining Acute Responses to Exercise in Symptomatic Females and Males With Atrial Fibrillation: a Pilot Randomized Crossover Study

Ottawa Heart Institute Research Corporation1 site in 1 country36 target enrollmentFebruary 8, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Ottawa Heart Institute Research Corporation
Enrollment
36
Locations
1
Primary Endpoint
Feasibility of the pilot study - Recruitment and consent rate
Status
Recruiting
Last Updated
5 months ago

Overview

Brief Summary

The main purpose of this pilot project is to measure the feasibility of conducting a randomized crossover study examining short-term changes in atrial fibrillation (AF) symptoms in symptomatic females and males with paroxysmal or persistent AF when they engage in a standard week of exercise (i.e. moderate-intensity continuous training [MICT] or high-intensity interval training [HIIT]) compared to a control week (i.e. no moderate to vigorous exercise over 7 days).

Detailed Description

Exercise training (e.g. 8 to 12-week exercise programs) has been shown to improve cardiorespiratory fitness and QoL, and reduce atrial fibrillation (AF) symptoms and time in AF in patients with AF. However, regular exercise participation is hindered by patient concerns regarding an increase in AF symptoms and episodes during or following an exercise session. Patients with AF also worry about potential negative consequences of increasing heart rate during exercise. This fear may be sex-specific as females report more AF symptoms at rest, experience faster heart rates during exercise and AF, and report greater symptoms of fear/anxiety than males. How exercise acutely changes AF symptoms remains to be examined. The main purpose of this pilot project is to measure the feasibility of conducting a randomized crossover study examining short-term changes in AF symptoms in symptomatic females and males with paroxysmal or persistent AF when they engage in a standard week of exercise (i.e. moderate-intensity continuous training \[MICT\] or high-intensity interval training \[HIIT\]) compared to a control week (i.e. no moderate to vigorous exercise over 7 days). As secondary outcomes we will explore sex differences in short-term changes in AF symptoms (self reported with a questionnaire) and AF status (device measured with a wireless four-finger AliveCor KardiaMobile ECG) when symptomatic patients with AF engage in a standard week of exercise (i.e. HIIT, MICT) compared to a control week. Results from this pilot study will provide novel insight into the typical acute response to exercise in females and males with AF, and will inform appropriate approaches for the conduct of a future larger trial. This work is key to informing practitioners and patients of the typical acute exercise response in the AF population with the goal of facilitating exercise prescription and participation.

Registry
clinicaltrials.gov
Start Date
February 8, 2022
End Date
April 1, 2026
Last Updated
5 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Paroxysmal and Persistent AF
  • Rate controlled (resting ventricular rate \<110 bpm)
  • Able to do a symptom limited exercise test
  • At least 40 years of age
  • Self-reports being symptomatic in the past 4 weeks
  • If female, self-reports being post-menopausal
  • Able to read and understand English or French
  • Agrees to sign informed consent

Exclusion Criteria

  • Currently participating in routine exercise training
  • Unstable angina or uncontrolled diabetes mellitus; or established diagnosis of severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy with significant obstruction
  • Unable to access the Internet or a phone (iPhone and iPad require iOS version 10.0 and up, Android requires version 6.0 and up) during the study period
  • Has an automated external defibrillator, an implantable cardioverter defibrillator or other types of pacemaker
  • Unwilling or unable to complete the three conditions
  • Unable to provide written, informed consent

Outcomes

Primary Outcomes

Feasibility of the pilot study - Recruitment and consent rate

Time Frame: Through study completion, an average of 1.5 years

Feasibility of the pilot study - Participant fidelity

Time Frame: During the week of HIIT and MICT (2 weeks)

E.g. ability of participants to comply with the exercise prescription, number of exercise sessions attended

Feasibility of the pilot study - Study retention

Time Frame: Through study completion, an average of 1.5 years

Dropout rate of participants

Feasibility of the pilot study - Study eligibility refinement

Time Frame: Through study completion, an average of 1.5 years

Data to refine inclusion and exclusion criteria for a larger trial will be used by balancing safety, ability to complete the intervention, and generalizability (e.g. is an exclusion criterion of threshold of participation in \>2 structured exercise sessions/week sufficient or restrictive?)

Feasibility of the pilot study - Adverse events

Time Frame: Through study completion, an average of 1.5 years

Side effects and adverse events during the study

Secondary Outcomes

  • AF status measured daily with a KardiaMobile device(3 weeks (1 week of HIIT, 1 week of MICT, 1 week fo rest))
  • AF symptoms self-reported with a 7-day patient symptom questionnaire(3 weeks (1 week of HIIT, 1 week of MICT, 1 week fo rest))

Study Sites (1)

Loading locations...

Similar Trials